Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen-

Authors
R. Lalonde, M. Dumont, M. Staufenbiel, C. Strazielle.


Lab
Université de Rouen, Faculté de Médecine et de Pharmacie, INSERM U614, Rouen, France ; CHUM/St-Luc, Neuroscience Research Center, Montreal, Canada ; Novartis Institutes for Biomedical Research, Nervous System Research, Basel, Switzerland ; Université Henr

Journal
Behavioural Brain Research

Abstract
The SHIRPA primary screen comprises 40 measures covering various reflexes and basic sensorimotor functions. This multi-test battery was used to compare non-transgenic controls with APP23 transgenic mice, expressing the 751 isoform of human beta-amyloid precursor protein and characterized by amyloid deposits in parenchyma and vessel walls. The APP23 mice were distinguishable from controls by pathological limb reflexes, myoclonic jumping, seizure activity, and tail malformation. In addition, this mouse model of Alzheimer’s disease was also marked by a crooked swimming trajectory. APP23 mice were also of lighter weight and were less inclined to stay immobile during a transfer arousal test. Despite the neurologic signs, APP23 transgenic mice were not deficient in stationary beam, coat-hanger, and rotorod tests, indicating intact motor coordination abilities.

BIOSEB Instruments Used:
Aron Test or Four Plates Test (LE830),Rotarod (BX-ROD)

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.